Medication Need - Trikafta 3
Closed State & local contract opportunity Posted
- Solicitation number
- 2138461
- State
- New York
- Responses due
Opportunity facts
- Point of contact
-
- Kathleen Belmonte kathleen.belmonte@ocfs.ny.gov (518) 473-5644
Updated .
About this opportunity
The New York Office of Children and Family Services (OCFS) is soliciting medication procurement for Trikafta to treat cystic fibrosis for an at-risk youth in custody, with proposals due September 2, 2026.
Trikafta must be dispensed through a specialty pharmacy — the defining scope constraint. The medication treats the underlying genetic mutation causing cystic fibrosis, slowing disease progression and extending life expectancy for eligible patients.
No contract value, contract term, evaluation criteria, or competitive details are specified in the source.
Opportunity text
OCFS has the need to obtain the medication Trikafta in order to treat Cystic Fibrosis for an at-risk youth in custody. Trikafta treats the mutation causing cystic fibrosis. It not only improves symptoms but slows the progression of the disease overall. It has been abreakthrough medication for people with cystic fibrosis, allowing them to plan on living longer and to participate in life more fully. Trikafta is a specialty medication that can only be filled by a specialty pharmacy.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Similar opportunities
- Ask GovTribe AI about this opportunity